SCHEMBL26356238

SCHEMBL26356238

C#CCN(c1ccc(NS(=O)(=O)c2ccc(OC)cc2)c2ccccc12)[C@@H](C)CC(=O)O

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 19/20 0.60
▸ NFE2L2 Q16236 9/20 0.60
▸ SQSTM1 Q13501 1/20 0.54
▸ MITF O75030 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ TP53 P04637 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ THRB P10828 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ CASP1 P29466 1/20 0.51
▸ GFER P55789 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ HKDC1 Q2TB90 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26356347 0.93 KEAP1 (0.57) KEAP1NFE2L2SQSTM1MITFALDH1A1
SCHEMBL22922455 0.92 KMT2A (0.47) KEAP1NFE2L2SQSTM1GAAHKDC1
SCHEMBL29539804 0.92 KMT2A (0.47) KEAP1NFE2L2SQSTM1GAAHKDC1
SCHEMBL29539949 0.91 KEAP1 (0.56) KEAP1NFE2L2SQSTM1
SCHEMBL26356973 0.91 KEAP1 (0.56) KEAP1NFE2L2SQSTM1
SCHEMBL26356913 0.90 KEAP1 (0.51) KEAP1NFE2L2LMNAHKDC1
SCHEMBL29539744 0.90 KEAP1 (0.51) KEAP1NFE2L2LMNAHKDC1
SCHEMBL24299708 0.89 HKDC1 (0.47) KEAP1NFE2L2HKDC1
SCHEMBL29539625 0.89 KEAP1 (0.48) KEAP1NFE2L2SQSTM1TP53GAA
SCHEMBL22922652 0.89 KEAP1 (0.50) KEAP1NFE2L2HKDC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773057-B2 Naphthalenesulfonamide compound, preparation method, and application CHINA PHARMACEUTICAL UNIVERSITY (CN) 2023-10-03 — — US disclosed
US-11773057-B2 Naphthalenesulfonamide compound, preparation method, and application CHINA PHARMACEUTICAL UNIVERSITY (CN) 2023-10-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773057-B2 Naphthalenesulfonamide compound, preparation method, and application NFE2L2, KEAP1, NFE2 KEAP1 2/4885NFE2L2 1/4885SQSTM1 914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback